Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian M Waszak

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
European Urology|June 6, 2022
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group StudyDaniel Burns, Ezequiel Anokian, Edward J Saunders, et al.
Neuro-Oncology|May 23, 2022
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline gliomaDana Messinger, Micah K Harris, Jessica R Cummings, et al.
Nature|January 28, 2016
Active medulloblastoma enhancers reveal subgroup-specific cellular originsCharles Y Lin, Serap Erkek, Yiai Tong, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Neuro-Oncology|March 12, 2025
Germline analysis of an international cohort of pediatric diffuse midline glioma patientsMarion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, et al.
Cancer Cell|May 16, 2025
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosisDerek Dang, Akash Deogharkar, John McKolay, et al.
Nature|February 7, 2020
Genomic basis for RNA alterations in cancer, Claudia Calabrese, Natalie R Davidson, et al.
Nature|January 25, 2023
Author Correction: Genomic basis for RNA alterations in cancer, Claudia Calabrese, Natalie R Davidson, et al.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cancer Cell|May 16, 2025
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic targetShiekh Tanveer Ahmad, Yiran Li, Jesus Garcia-Lopez, et al.
European Urology|June 6, 2022
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group StudyDaniel Burns, Ezequiel Anokian, Edward J Saunders, et al.
Neuro-Oncology|May 23, 2022
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline gliomaDana Messinger, Micah K Harris, Jessica R Cummings, et al.
Nature|January 28, 2016
Active medulloblastoma enhancers reveal subgroup-specific cellular originsCharles Y Lin, Serap Erkek, Yiai Tong, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Neuro-Oncology|March 12, 2025
Germline analysis of an international cohort of pediatric diffuse midline glioma patientsMarion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, et al.
Cancer Cell|May 16, 2025
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosisDerek Dang, Akash Deogharkar, John McKolay, et al.
Nature|February 7, 2020
Genomic basis for RNA alterations in cancer, Claudia Calabrese, Natalie R Davidson, et al.
Nature|January 25, 2023
Author Correction: Genomic basis for RNA alterations in cancer, Claudia Calabrese, Natalie R Davidson, et al.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Pageof 8